Abstract:Endothelial progenitor cells (EPCs) are capable of enhancing re-endothelialization and attenuating neointimal formation. However, inefficient homing limits the therapeutic efficacy of EPCs transplantation. CXCR4 plays a critical role in regulating EPCs homing. Here, we studied the effect of Foxc2 overexpression on CXCR4 expression and the homing capacity of EPCs as well as the EPCs-mediated therapeutic benefit after artery injury.Bone marrow-derived EPCs were transfected with Foxc2 expression vector (Foxc2-EPCs) or empty control vector (Ctrl-EPCs) and examined 48 hours later. CXCR4 expression of EPCs was detected by flow cytometry and quantitative reverse transcriptase-polymerase chain reaction. The migration of EPCs toward SDF-1α was evaluated in a transwell migration assay, and the adhesion to fibronectin was determined using a static adhesion assay. For in vivo studies, EPCs were injected intravenously into the mice subjected to carotid injury. At 3 days after green fluorescent protein (GFP)/EPCs delivery, the recruited cells to the injury sites were detected by fluorescent microscopy. Re-endothelialization and neointimal formation were, respectively, assessed by Evans blue dye at 7 days and by the morphometric analysis for neointima and media area ratio (N/M) at 28 days after EPCs transfusion.Foxc2 overexpression significantly increased the surface expression of CXCR4 on EPCs (about 1.9-fold of Ctrl-EPCs, P < .05). Foxc2-EPCs showed an increased migration toward SDF-1α (P < .05); Foxc2 overexpression increased also the adhesion capacity of EPCs (P < .05). In vivo, the number of recruited GFP cells was significantly higher in the mice transfused with Foxc2-GFP/EPCs compared with Ctrl-GFP/EPCs (about 2-fold of Ctrl-GFP/EPCs). The degree of re-endothelialization was higher in mice transfused with Foxc2-EPCs compared with Ctrl-EPCs (90.3% ± 1.6% vs 57.2% ± 1.3%; P < .05). Foxc2-EPCs delivery resulted in a greater inhibition of neointimal hyperplasia than Ctrl-EPCs administration (N/M: 0.38 ± 0.03 vs 0.67 ± 0.05, P < .05). Preincubation with CXCR4-Ab, AMD3100, or LY294002 significantly attenuated the enhanced in vitro and in vivo effects of Foxc2-EPCs.Our findings indicate that Foxc2 overexpression increases CXCR4 expression of EPCs and efficiently enhances the homing potential of EPCs, thereby improving EPCs-mediated therapeutic benefit after endothelial injury. Foxc2 may be a novel molecular target for improving the therapeutic efficacy of EPCs transplantation.

Cxcl12 Gene Engineered Endothelial Progenitor Cells Further Improve the Functions of Oligodendrocyte Precursor Cells

cxcl12 -engineered endothelial progenitor cells enhance neurogenesis and angiogenesis after ischemic brain injury in mice

Cxcl12 Gene Therapy Ameliorates Ischemia-Induced White Matter Injury In Mouse Brain

Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A/cAMP signaling pathway

Lipocalin-2-Mediated Insufficient Oligodendrocyte Progenitor Cell Remyelination for White Matter Injury after Subarachnoid Hemorrhage Via SCL22A17 Receptor/Early Growth Response Protein 1 Signaling

Oligodendrocyte Precursor Cells Transplantation Improves Stroke Recovery<i> via</i> Oligodendrogenesis, Neurite Growth and Synaptogenesis

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Ectoderm Mesenchymal Stem Cells Promote Differentiation and Maturation of Oligodendrocyte Precursor Cells.

Infusion of Endothelial Progenitor Cells Accelerates Hematopoietic and Immune Reconstitution, and Ameliorates the Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation

17β-Estradiol Enhances Schwann Cell Differentiation via the ERβ-ERK1/2 Signaling Pathway and Promotes Remyelination in Injured Sciatic Nerves

17 Beta-Estradiol Enhances Schwann Cell Differentiation Via The Er Beta-Erk1/2 Signaling Pathway And Promotes Remyelination In Injured Sciatic Nerves

Foxc2 overexpression enhances benefit of endothelial progenitor cells for inhibiting neointimal formation by promoting CXCR4-dependent homing.

Human iPSC-derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway

Oligodendrocyte precursor cell transplantation promotes angiogenesis and remyelination via Wnt/<b>β</b>-catenin pathway in a mouse model of middle cerebral artery occlusion

Oligodendrocyte precursor cell transplantation promotes angiogenesis and remyelination via Wnt/beta-catenin pathway in a mouse model of middle cerebral artery occlusion

Monomeric CXCL12 outperforms its dimeric and wild type variants in the promotion of human endothelial progenitor cells’ function

Endothelial Progenitor Cell Transplantation Attenuated Synaptic Loss by Enhancing CR3 Dependent Microglial Phagocytosis in Mice

Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

Preventing production of new oligodendrocytes impairs remyelination and sustains behavioural deficits after demyelination

CXCL12/CXCR4/CXCR7 Chemokine Axis in the Central Nervous System: Therapeutic Targets for Remyelination in Demyelinating Diseases

Exogenous Endothelial Progenitor Cells Reached the Deficient Region of Acute Cerebral Ischemia Rats to Improve Functional Recovery Via Bcl-2.